Columns - DARWIN REDUX - By ditching fledgling drug companies for dot-coms, investors unknowingly purified the biotech gene pool.
|Year of publication:||
Forbes : business and finance. - New York, NY : Forbes Publ. Co., ISSN 0015-6914, ZDB-ID 7162637. - 2001 (19.02.), SUPPL, p. 116-119
Robbins-Roth, Cynthia, (2001)
Features - BUY OR DIE - In this excerpt from her book, From Alchemy to IPO: The Business of Biotechnology, Forbes ASAP's resident biogoddess debunks hard-and-fast myths about the risks of investing in cutting-edge medicine and drug development
Robbins-Roth, Cynthia, (2000)
Robbins-Roth, Cynthia, (1998)
- More ...